Lucira Health announced on Thursday that it has received authorization under an interim order from Health Canada to market the Lucira COVID-19 & Flu Test for emergency use.

Following extraordinary demand for rapid COVID-19 antigen testing in 2021, Siemens Healthineers reported on Wednesday that the company's fiscal third quarter COVID-19 testing revenue declined sharply

Rising demand for core diagnostics offset better-than-feared declines in COVID-19 test sales, shedding light on the companies’ post-pandemic futures.

Recently, Wondfo's 2019-nCoV Antigen Test (Lateral Flow Method) is listed by WHO (World Health Organization) for emergency use listing (EUL), available for purchase in other countries and regions in worldwide.

On July 17, a reporter from People’s Daily Health Channel learned from Guangdong Academy of Sciences that Professor Wu Wenming, deputy director of the National Medical and Health Device Engineering Technology Research Center and scholar of the Hundred Talents Program of the Chinese Academy of Sciences

The director of Columbia University’s Center for Infection and Immunity talked about problems with antigen tests and the need for continued investment in COVID-19 testing.

Recently, Hotgen Coronavirus (2019-nCoV)-Antigentest has officially passed 3a validation of the UK Department of Health and Social Care (DHSC), which proves that the antigen test not only has high specificity, but also has high detection sensitivity.

Color Health said on Friday that it has partnered with the US Centers for Disease Control and Prevention to increase access to no-cost, PCR-based, COVID-19 testing.

The World Health Organization's COVID-19 Technology Access Pool (C-TAP) initiative has entered into a nonexclusive sublicense agreement with Biotech Africa to manufacture a serology assay to detect previous SARS-CoV-2 infection.

Consumer advocates say the proposed legislation has too many exemptions, while industry groups seek to limit premarket review requirements for legacy tests.